ReviewCancer immunology, immunotherapy : CII2023

The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma.

Liqiu Kou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.